Products for Research Use Only
RegisterLogin

Pagibaximab

CAT: 0804-HY-P99309-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99309-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1].
CAS Number
595566-61-3
Product Name Alternative
BSYX-A 110; Anti-S. Epidermidis LTA Recombinant Antibody
UNSPSC
12352203
Target
Bacterial
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/pagibaximab.html
Purity
98.81
Solubility
H2O
Smiles
[Pagibaximab]
Molecular Weight
(145.42 kDa)
References & Citations
[1]Weisman LE, et, al. A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis. Pediatrics. 2011 Aug;128 (2) :271-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
BA1477-1Pagibaximab
GTR18337959-01Pagibaximab Antibody
MBS1563242-01Research Grade Pagibaximab
E55B0631Pagibaximab (Reference antibody)
ICH5753-1mgPagibaximab Biosimilar - Research Grade
GTR18698179-01Pagibaximab Chimeric Monoclonal Antibody
592093Pagibaximab (Staphylococcus epidermidis lipoteichoic acid)
A135271Pagibaximab Biosimilar (Monoclonal, IgG1-kappa)
10-271Pagibaximab (Staphylococcus epidermidis lipoteichoic acid) - Research Grade Biosimilar
GTR18117344Pagibaximab (Staphylococcus epidermidis lipoteichoic acid) - Research Grade Biosimilar Antibody

Popular Products